The mysterious RAMP proteins and their roles in small RNA-based immunity

被引:20
|
作者
Wang, Ruiying [1 ]
Li, Hong [1 ,2 ]
机构
[1] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA
[2] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA
基金
美国国家科学基金会;
关键词
RNA-mediated Immunity; RNA-binding proteins; RNA processing; RNA-protein interactions; CRISPR; CRISPR RNA; NONCODING RNA; RECOGNITION; SYSTEM; BACTERIA; ARCHAEA; INTERFERENCE; CLEAVAGE; REPEATS; COMPLEX;
D O I
10.1002/pro.2044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new class of prokaryotic RNA binding proteins called Repeat Associated Mysterious Proteins (RAMPs), has recently been identified. These proteins play key roles in a novel type immunity in which the DNA of the host organism (e.g. a prokaryote) has sequence segments corresponding to the sequences of potential viral invaders. The sequences embedded in the host DNA confer immunity by directing selective destruction of the nucleic acid of the virus using an RNA-based strategy. In this viral defense mechanism, RAMP proteins have multiple functional roles including endoribonucleotic cleavage and ribonucleoprotein particle assembly. RAMPs contain the classical RNA recognition motif (RRM), often in tandem, and a conserved glycine-rich segment (G-loop) near the carboxyl terminus. However, unlike RRMs that bind single-stranded RNA using their beta-sheet surface, RAMPs make use of both sides of the RRM fold and interact with both single-stranded and structured RNA. The unique spatial arrangement of the two RRM folds, facilitated by a hallmark G-loop, is crucial to formation of a composite surface for recognition of specific RNA. Evidence for RNA-dependent oligomerization is also observed in some RAMP proteins that may serve as an important strategy to increase specificity.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [21] RNA interference in vivo:: Toward synthetic small inhibitory RNA-based therapeutics
    De Fougerolles, A
    Manoharan, M
    Meyers, R
    Vornlocher, HP
    RNA INTERFERENCE, 2005, 392 : 278 - 296
  • [22] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2019, 37 (02) : 129 - 129
  • [23] RNA-based therapies
    Nature Biotechnology, 2023, 41 : 1071 - 1071
  • [24] A RNA-Based Approach towards Small-Molecule Inhibitors
    Mayer, Guenter
    Faulhammer, Dirk
    Graettinger, Mira
    Fessele, Sabine
    Blind, Michael
    CHEMBIOCHEM, 2009, 10 (12) : 1993 - 1996
  • [25] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2023, 41 (08) : 1071 - 1071
  • [26] RNA-based therapies
    Irena Melnikova
    Nature Reviews Drug Discovery, 2007, 6 : 863 - 864
  • [27] RNA-based therapies
    Nature Biotechnology, 2019, 37 : 129 - 129
  • [28] RNA-based reprogramming
    Baker, Monya
    NATURE METHODS, 2011, 8 (01) : 18 - 18
  • [29] RNA-based therapies
    Melnikova, Irena
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) : 863 - 864
  • [30] RNA-based vaccines
    Ulmer, Jeffrey B.
    Mason, Peter W.
    Geall, Andrew
    Mandl, Christian W.
    VACCINE, 2012, 30 (30) : 4414 - 4418